Cephalon regulatory update

Cephalon Inc. (CEPH) CEPH (West Chester, Penn.) received U.S. Patent No. 5,420,112 covering the use of Myotrophin (rh IGF-1) to treat peripheral neuropathy caused by certain anti-cancer agents. Myotr...